Stem Cells International / 2016 / Article / Fig 1

Review Article

Mesenchymal Stem Cells as Therapeutics Agents: Quality and Environmental Regulatory Aspects

Figure 1

Scheme of environmental control requirements for the manufacture of SCMPs in cell therapy laboratories for the monitorization of viable and nonviable particles.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.